An expert discusses how rilzabrutinib, a recently FDA-approved Bruton tyrosine kinase inhibitor, targets the autoimmune pathophysiology of ITP by modulating B cells, macrophages, and reducing ...

An expert discusses how current ITP treatments like corticosteroids, rituximab, and fostamatinib have significant tolerability issues and fail to provide sustained platelet responses or address ...

Medicare beneficiaries face confusion in selecting plans, with 75% finding the process challenging and many unaware of ...

At the European Respiratory Society Congress 2025, Lucilla Piccari, MD, PhD, a pulmonologist at Hospital del Mar in Barcelona, Spain, discussed the profound impact of social inequality, environmental ...

Timothy W. Cutler, PharmD, associate chief of ambulatory care at UC Davis Health, describes how pharmacy services patients healthy and out of the hospital.

Telehealth and home care services face potential disruptions, impacting rural and mobility-limited patients, with possible ...

Several actions taken by the current administration may affect the landscape of prevention of HIV, prompting an analysis of these effects.

Vivek Subbiah, MD, considers artificial intelligence (AI) and comprehensive somatic and germline testing essential for guiding precision oncology and improving patient care.

Compared with SNRA, SPRA was linked to a 29% higher risk of pneumonia and a 58% higher risk of hospitalization. Researchers noted that seropositivity may reflect greater systemic inflammation and ...

Despite an executive order aimed at addressing homelessness in the US, defunding vital programs could spell difficulty in helping the homeless.

Primary aldosteronism is often overlooked in hypertension. Educating providers and utilizing tools can enhance screening and treatment effectiveness, emphasizes Vivek Bhalla, MD, Stanford.

AJMC: Osimertinib is an oral drug, whereas amivantamab is an intravenous formulation. Given those differences in delivery mechanisms, how do physicians need to change up workflows for the ...